Alterations in TDG expression are a biomarker for melanoma and colorectal cancers (CRCs) (Mancuso et al. 2019; Tricarico et al. 2023) and play a role with TET1 in genomic instability through DNA demethylation and inflammation. This evidence concerns the gene TDG and melanoma.